PCM
ABBV icon

Permanent Capital Management’s AbbVie ABBV Stock Holding History

Permanent Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$772K Buy
3,622
+71
+2% +$15.7K 0.12% 60
2025
Q4 		$811K Buy
3,551
+442
+14% +$101K 0.16% 63
2025
Q3 		$720K Buy
+3,109
New +$633K 0.13% 69
2025
Q1 		$651K Buy
3,109
+1,816
+140% +$353K 0.19% 27
2024
Q4 		$230K Buy
+1,293
New +$238K 0.07% 60
2024
Q2 		$577K Buy
+3,109
New +$515K 0.12% 76

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Permanent Capital Management's ABBV Position: Q1 2026 in Review

Permanent Capital Management increased its AbbVie (ABBV) stake by 2% in Q1 2026, buying an estimated $15.7K and bringing the position to 3,622 shares worth $772K. The position accounts for 0.12% of the portfolio, ranked #60.

Permanent Capital Management first reported a position in ABBV in Q2 2024 and has held it in 6 quarters since. The position peaked at $811K in Q4 2025. 4,084 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Permanent Capital Management held 3,622 shares of AbbVie worth $772K as of Q1 2026.
  • Permanent Capital Management bought 71 AbbVie shares in Q1 2026, an estimated $15.7K.
  • AbbVie made up 0.12% of Permanent Capital Management's portfolio in Q1 2026, its #60 holding.
  • Permanent Capital Management first reported a position in AbbVie in Q2 2024 and has held it in 6 quarters since.
  • Permanent Capital Management's AbbVie position peaked at $811K in Q4 2025.
  • 4,084 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Permanent Capital Management's 13F filing for Q1 2026, filed 14 May 2026.